Growth Metrics

Forte Biosciences (FBRX) Return on Sales (2016 - 2020)

Historic Return on Sales for Forte Biosciences (FBRX) over the last 5 years, with Q4 2020 value amounting to 12.43%.

  • Forte Biosciences' Return on Sales rose 11883200.0% to 12.43% in Q4 2020 from the same period last year, while for Dec 2020 it was 12.43%, marking a year-over-year increase of 17767600.0%. This contributed to the annual value of 1764.33% for FY2019, which is 17616200.0% down from last year.
  • According to the latest figures from Q4 2020, Forte Biosciences' Return on Sales is 12.43%, which was up 11883200.0% from 26.74% recorded in Q3 2020.
  • Over the past 5 years, Forte Biosciences' Return on Sales peaked at 52.46% during Q2 2020, and registered a low of 2178.11% during Q4 2018.
  • Moreover, its 5-year median value for Return on Sales was 452.21% (2017), whereas its average is 762.58%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -20816500bps in 2019, then skyrocketed by 21084100bps in 2020.
  • Quarter analysis of 5 years shows Forte Biosciences' Return on Sales stood at 16.21% in 2016, then tumbled by -6786bps to 1083.7% in 2017, then crashed by -101bps to 2178.11% in 2018, then surged by 46bps to 1175.89% in 2019, then soared by 101bps to 12.43% in 2020.
  • Its last three reported values are 12.43% in Q4 2020, 26.74% for Q3 2020, and 52.46% during Q2 2020.